MASH
Clinical trials for MASH explained in plain language.
Never miss a new study
Get alerted when new MASH trials appear
Sign up with your email to follow new studies for MASH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First human test for new MASH liver drug begins
Disease control OngoingThis early-stage study is testing the safety and initial effects of an investigational drug called RO7790121 in 50 people with advanced MASH-related liver scarring (fibrosis). The main goal is to see how well the drug is tolerated and how it behaves in the body. Researchers will …
Matched conditions: MASH
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
First human tests begin for new liver disease drug
Knowledge-focused OngoingThis is a very early-stage study to check the safety of a new drug called CS060304, which is being developed for a liver condition called MASH. The study will involve 80 healthy volunteers and people with high cholesterol to see how their bodies handle single and multiple doses o…
Matched conditions: MASH
Phase: PHASE1 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC